Share this article
Share this article
SHANGHAI, April 8, 2021 /PRNewswire/ Shanghai Genechem Co., Ltd. (Genechem), a discovery company dedicated to novel target discovery and development of novel therapeutics, today announced the appointment of Dr. Eric Rowinsky, President and Executive Chairman of the Board of Rgenix, Inc., and Dr. Manuel Hidalgo, Chief of Hematology and Medical Oncology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, to its Scientific Advisory Board. Drs. Rowinsky and Hidalgo will bring their strong expertise in translational and clinical development to support Genechem s mission to bring its innovative pipeline to global markets through novel target discovery, early development in China, and global partnership.
Florida Cancer Specialists & Research Institute Appoints Gustavo Fonseca, MD, FACP as Medical Director of Clinical Research Program
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Barbara Ireland Walk & Run Supports Breast Cancer Programs at Ridley-Tree Cancer Center
noozhawk.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from noozhawk.com Daily Mail and Mail on Sunday newspapers.